Canada - English - Health Canada

ge healthcare canada inc - iodixanol - solution - 652mg - iodixanol 652mg - roentgenography

Canada - English - Health Canada

bracco imaging canada - iopamidol - solution - 41% - iopamidol 41% - roentgenography

Canada - English - Health Canada

bracco imaging canada - iopamidol - liquid - 61% - iopamidol 61% - roentgenography

Canada - English - Health Canada

bracco imaging canada - iopamidol - liquid - 76% - iopamidol 76% - roentgenography

Canada - English - Health Canada

novo nordisk canada inc - estradiol - vaginal tablet - 25mcg - estradiol 25mcg - estrogens

Canada - English - Health Canada

bracco imaging canada - iopamidol - liquid - 76% - iopamidol 76% - roentgenography

Canada - English - Health Canada

bracco imaging canada - iopamidol - liquid - 61% - iopamidol 61% - roentgenography

Canada - English - Health Canada

novo nordisk canada inc - estradiol (estradiol hemihydrate) - vaginal tablet - 10mcg - estradiol (estradiol hemihydrate) 10mcg - estrogens

Canada - English - Health Canada

allergan inc - ulipristal acetate - tablet - 5mg - ulipristal acetate 5mg - contraceptives

United States - English - NLM (National Library of Medicine)

bracco diagnostics inc - iopamidol (unii: jr13w81h44) (iopamidol - unii:jr13w81h44) - iopamidol 612 mg in 1 ml - isovue (iopamidol injection) is indicated for angiography throughout the cardiovascular system in adults, including cerebral and peripheral arteriography, coronary arteriography and ventriculography, selective visceral arteriography and aortography, peripheral venography (phlebography), and in pediatric patients for angiocardiography; or for intravenous use in adult and pediatric for computed tomographic (ct) imaging of the head and body (see below). ct head imaging isovue may be used to refine diagnostic precision in areas of the brain which may not otherwise have been satisfactorily visualized. tumors isovue may be useful to investigate the presence and extent of certain malignancies such as: gliomas including malignant gliomas, glioblastomas, astrocytomas, oligodendrogliomas and gangliomas, ependymomas, medulloblastomas, meningiomas, neuromas, pinealomas, pituitary adenomas, craniopharyngiomas, germinomas, and metastatic lesions. the usefulness of contrast enhancement for the investigation of the ret